Design, Synthesis and Biological Evaluation of New 1,3-diphenyl-3- (phenylamino)propan-1-ones as Selective Cyclooxygenase (COX-2) Inhibitors

By  

Medicinal Chemistry, Vol. 14, Iss. 7, 2018-11 ,pp. : 652-659

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

By de Gaetano G.   Donati M.B.   Cerletti C.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

New studies confirm GI safety of COX-2 inhibitors

By  

Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors: An Update

By Song J.C.  

Clinical Pharmacokinetics, Vol. 41, Iss. 3, 2002-01 ,pp. : 207-224

Adis International

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of New imidazo[1,2-a]pyridine Derivatives as Selective COX-2 Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-08 ,pp. : 793-799

Bentham Science Publishers

Access to resources Recommend Favorite